General Surgery
Final Professional MBBS — General Surgery. Explanation-first answers that teach the reasoning behind every fact, with classifications, comparison tables, drug doses, clinical pearls and key-point recaps from Bailey & Love and SRB's Manual.
THE CONCEPT & A USEFUL RULE
Salivary gland tumours arise mostly in the parotid gland (about 80%), less often in the submandibular gland, and least in the minor salivary glands. There is a single elegant rule that organises the topic: the smaller the gland, the more likely a tumour in it is malignant. So most parotid tumours are benign (~80%), whereas about half of minor salivary gland tumours are malignant. This inverse relationship guides how worried you are about any given salivary swelling.
CLASSIFICATION
Tumour Notes Benign Pleomorphic adenoma Commonest salivary tumour ('mixed' tumour); recurs if enucleated Warthin's tumour (adenolymphoma) Older men, smokers, can be bilateral, cystic Malignant Mucoepidermoid carcinoma Commonest salivary malignancy Adenoid cystic carcinoma Perineural spread, late lung metastases Carcinoma ex-pleomorphic adenoma Malignant change in a long-standing adenoma CLINICAL FEATURES — BENIGN VS MALIGNANT
A benign tumour is typically a slow-growing, painless, smooth, mobile lump — a pleomorphic adenoma classically appears as a swelling over the angle of the jaw or in the parotid tail. The features that signal malignancy are the ones to look for actively: rapid growth, pain, a hard or fixed lump, skin or deep-structure infiltration, cervical lymphadenopathy, and — most importantly for a parotid mass — a facial nerve palsy, because the facial nerve runs through the parotid and a malignant tumour infiltrates it.
INVESTIGATION
Assessment uses FNAC (to obtain a tissue diagnosis), ultrasound, and MRI (to define the extent and whether the deep lobe or facial nerve is involved). An important principle is to avoid open incisional biopsy of a parotid mass, because it risks seeding tumour and damaging the facial nerve — the diagnosis is made by needle, and the definitive excision provides the full histology.
MANAGEMENT
- Benign parotid tumour (pleomorphic adenoma) — superficial parotidectomy (removing the superficial lobe containing the tumour) with careful preservation of the facial nerve. Simple enucleation is avoided because the tumour has microscopic extensions through an incomplete capsule and recurs.
- Submandibular tumour — excision of the whole gland.
- Malignant tumour — radical excision (sacrificing the facial nerve only if it is directly involved), neck dissection for nodal disease, and post-operative radiotherapy.
💡CLINICAL PEARL: Two rules dominate the vivas. First, a facial nerve palsy with a parotid lump means malignancy until proven otherwise — a benign tumour, however large, does not paralyse the nerve. Second, never enucleate a pleomorphic adenoma: its pseudopod-like extensions through the capsule cause recurrence, so a superficial parotidectomy is performed.THE FACIAL NERVE & PAROTID ANATOMY
The facial nerve is the central character in parotid surgery: it enters the gland and divides it into an artificial superficial and deep lobe, its branches fanning out over the face. This is why a superficial parotidectomy — which removes the part of the gland superficial to the nerve — can treat most benign tumours while sparing facial movement, and why identifying and preserving the nerve trunk (found at landmarks such as the tragal pointer) is the crux of the operation. Deep-lobe tumours are more challenging and may present as a parapharyngeal swelling.
COMPLICATIONS OF PAROTIDECTOMY
The complications follow the anatomy: facial nerve injury (temporary neuropraxia or permanent palsy), Frey's syndrome (gustatory sweating from aberrant nerve regeneration), a salivary fistula or sialocele, greater auricular nerve numbness of the ear lobe, and haematoma. Knowing these allows proper consent and post-operative care.
DEEP-LOBE & PAROTID DUCT
Beyond the common superficial tumour, a deep-lobe parotid tumour may grow medially into the parapharyngeal space and present as a swelling of the soft palate or tonsil pushing it towards the midline, rather than as an obvious facial lump — a presentation worth recognising. The parotid also drains via Stensen's duct, which opens opposite the second upper molar; obstruction or a tumour here can cause recurrent parotid swelling. These anatomical facts explain the varied ways parotid pathology presents and why imaging (MRI) is used to map the deep lobe before surgery.
STAGING, GRADING & PROGNOSIS
Malignant salivary tumours are staged by the TNM system (size, nodal spread, metastasis) and graded histologically, both of which drive treatment intensity and prognosis. High-grade tumours (high-grade mucoepidermoid, adenoid cystic, salivary duct carcinoma) behave aggressively with nodal and distant spread, whereas low-grade tumours may be cured by surgery alone. Facial nerve involvement, extra-glandular extension and positive nodes all worsen the outlook. This is why the pre-operative assessment (FNAC grade, MRI extent, nodal status) matters so much: it separates the patient who needs only a superficial parotidectomy from the one who needs radical surgery, neck dissection and radiotherapy.
A CLINICAL SUMMARY
In summary, the assessment of a salivary swelling asks three questions: which gland, benign or malignant, and (for the parotid) is the facial nerve involved? A slow, painless, mobile parotid lump with an intact nerve is very likely a pleomorphic adenoma treated by superficial parotidectomy; pain, fixation, rapid growth, nodes or nerve palsy signal malignancy needing radical surgery and radiotherapy. This simple triad — gland, behaviour, nerve — organises the whole topic for the viva.
💊KEY POINTS (viva)- Parotid ~80% of tumours and ~80% benign; the smaller the gland, the higher the malignancy risk.
- Facial nerve palsy + parotid mass = malignancy until proven otherwise.
- Pleomorphic adenoma → superficial parotidectomy (not enucleation); avoid open biopsy of the parotid.
🔑KEY POINTS TO REMEMBER- Most salivary tumours are in the parotid (~80%) and benign; the smaller the gland, the higher the malignancy risk.
- Benign: pleomorphic adenoma (commonest, recurs if enucleated), Warthin's tumour (older men, bilateral, cystic). Malignant: mucoepidermoid (commonest malignant), adenoid cystic (perineural, lung mets).
- Malignant features: rapid growth, pain, hard/fixed, skin/node involvement, and facial nerve palsy (parotid).
- Investigate with FNAC, ultrasound, MRI; avoid open incisional biopsy of the parotid.
- Pleomorphic adenoma → superficial parotidectomy preserving the facial nerve; malignant → radical excision ± nerve sacrifice + neck dissection + radiotherapy.
📚SOURCES: Bailey & Love's Short Practice of Surgery; SRB's Manual of Surgery.THE CONCEPT — A SYSTEM FOR A COMMON PROBLEM
Neck swellings are common and have a wide differential, so the key skill is a systematic approach rather than memorising a long list. Three simple axes narrow the diagnosis quickly: the anatomical location of the swelling, the age of the patient, and the pathological category. Combining these, together with a focused examination, usually points to the diagnosis before any investigation.
BY LOCATION — MIDLINE VS LATERAL
Location is the first great divider. Midline swellings are few and specific: a thyroglossal cyst, a thyroid isthmus mass, a dermoid cyst, or a submental lymph node. Lateral swellings are far more numerous and are further localised by the anterior and posterior triangles — for example, a branchial cyst lies at the anterior border of sternocleidomastoid, while a cystic hygroma classically occupies the posterior triangle.
BY AGE
Age powerfully shifts the probabilities. In children and young adults, think of congenital lesions (thyroglossal cyst, branchial cyst, cystic hygroma) and reactive lymphadenopathy. In older adults, the emphasis shifts firmly towards neoplasia — a metastatic lymph node or lymphoma — which is why the same lump is approached very differently at 15 and at 65.
BY PATHOLOGY
It also helps to run through pathological categories: congenital (thyroglossal/branchial cyst, cystic hygroma), inflammatory (reactive or tuberculous lymphadenitis), neoplastic (metastatic node, lymphoma, salivary or thyroid tumour), and swellings of specific structures (thyroid, salivary glands, vascular such as a carotid body tumour).
HISTORY & EXAMINATION
The history notes duration and growth, pain, and associated symptoms (fever, weight loss, night sweats; ENT symptoms such as hoarseness, dysphagia or nasal obstruction). Examination defines the swelling's site, size, shape, consistency, mobility, fluctuation and transillumination (cystic lesions), pulsatility (vascular), and its movement on swallowing (thyroid) or tongue protrusion (thyroglossal cyst). Crucially it includes examining the likely primary sites — the scalp, oral cavity, and upper aerodigestive tract — and all other node groups.
INVESTIGATION
FNAC and ultrasound are the first-line investigations; CT/MRI defines extent, and in a suspected metastatic node an ENT panendoscopy searches for the primary. Blood tests are added as indicated.
💡CLINICAL PEARL: The overriding safety rule: a lump in the neck of an adult over 40 is a metastatic lymph node until proven otherwise — search for a head-and-neck primary before anything else. And never perform a blind excision biopsy of an undiagnosed node first: it can seed a squamous cancer and compromise a later neck dissection. FNAC and panendoscopy come first; excision biopsy is a last resort (and the investigation of choice only for suspected lymphoma).SPECIAL EXAMINATION TECHNIQUES
Certain bedside tests clinch specific diagnoses and are worth listing: transillumination (a cystic hygroma lights up brilliantly), pulsatility and a bruit (a carotid body tumour or aneurysm), movement on swallowing (thyroid) versus movement on tongue protrusion (thyroglossal cyst), compressibility and emptying (a vascular malformation), and side-to-side but not vertical mobility (a carotid body tumour). Eliciting the right sign often makes the diagnosis clinically before any scan.
A NOTE ON LEVELS
Surgeons describe cervical nodes by anatomical levels (I–VI), which matters because the level of a metastatic node predicts the likely site of the primary tumour — for example, upper (level II) nodes often relate to oropharyngeal primaries, and a left supraclavicular (Virchow's) node classically points to an abdominal (e.g. gastric) primary. This orderly drainage is what makes the neck examination so informative.
WORKING THROUGH A DIFFERENTIAL
In practice the clinician combines the axes: a midline swelling moving on tongue protrusion in a child is a thyroglossal cyst; a brilliantly transilluminable posterior-triangle swelling in an infant is a cystic hygroma; a fluctuant swelling at the upper anterior border of sternocleidomastoid in a young adult is a branchial cyst; a pulsatile lump splaying the carotid is a carotid body tumour; and a hard fixed node in an older smoker is a metastasis. Rehearsing these pattern-recognitions turns a daunting differential into a short, targeted list once the site, age and physical signs are known.
INVESTIGATIONS IN SEQUENCE
A logical investigation ladder avoids both under- and over-testing. Ultrasound with FNAC is the first-line workhorse — it distinguishes solid from cystic, characterises nodes, and yields cytology at the same sitting. Cross-sectional imaging (CT/MRI) then maps the extent, deep structures and other nodes. Blood tests (full blood count, and specific serology or LDH if lymphoma or infection is suspected) are added selectively, and an ENT panendoscopy is arranged for a suspected metastatic squamous node. The guiding idea is that each test is chosen to answer a specific question raised by the clinical assessment, not ordered reflexively.
PUTTING IT TOGETHER
The value of the systematic approach is that it converts anxiety about a long differential into a confident, targeted plan: define the swelling by location, age and physical signs; place it in a pathological category; confirm with FNAC and ultrasound; and, in any adult over 40, treat a persistent lump as a metastatic node until the upper aerodigestive tract has been cleared. Applied consistently, this scheme rarely misses a serious diagnosis.
🔑KEY POINTS TO REMEMBER- Approach a neck swelling systematically by location, age and pathology.
- Midline: thyroglossal cyst, thyroid isthmus, dermoid, submental node. Lateral: localise by anterior/posterior triangle.
- Children/young: congenital + reactive nodes; older adults: think neoplastic (metastatic node, lymphoma).
- Examine for consistency, fluctuation/transillumination, movement on swallowing/tongue protrusion, and the primary sites (scalp, oral cavity, aerodigestive tract).
- FNAC + ultrasound first; over-40 lump = metastatic node until proven otherwise (panendoscopy for the primary); avoid blind excision biopsy (except suspected lymphoma).
📚SOURCES: Bailey & Love's Short Practice of Surgery; SRB's Manual of Surgery.THE CONCEPT
Enlargement of the cervical lymph nodes is extremely common, and the whole art is separating the trivial from the sinister. The causes fall into three broad groups — reactive/inflammatory, specific infection (notably tuberculosis), and neoplastic (metastatic carcinoma or lymphoma) — and the character of the nodes plus the patient's age usually indicates which group is responsible.
CAUSES
- Reactive (inflammatory) — the commonest: acute tender nodes accompanying an upper respiratory, throat or dental infection, and chronic reactive nodes. These are soft, tender and mobile.
- Tuberculous lymphadenitis — a chronic, often matted group of nodes that may caseate to form a 'cold abscess', which can point through the deep fascia as a 'collar-stud' abscess and discharge as a chronic sinus. Other specific infections include HIV, toxoplasmosis and cat-scratch disease.
- Metastatic carcinoma — typically a hard, fixed node, most often squamous carcinoma from a head-and-neck primary (also thyroid and, at the left supraclavicular Virchow's node, from the abdomen).
- Lymphoma — characteristically rubbery, multiple, non-tender nodes, often with systemic 'B symptoms' (fever, night sweats, weight loss).
ASSESSMENT
The examination reads the nodes like a diagnostic text: their number and site, consistency (soft = reactive, rubbery = lymphoma, stony-hard = metastatic), mobility or fixity, tenderness, and matting (suggesting TB). One then searches for a primary in the head and neck and assesses for systemic features.
INVESTIGATIONS
FNAC is the first-line test and ultrasound characterises the nodes. For a suspected metastatic squamous node, an ENT panendoscopy with biopsy hunts for the primary. If lymphoma is suspected, an excision biopsy of a whole node is required — because diagnosis and subtyping depend on the architecture, which FNAC cannot show. Tuberculous nodes are confirmed by Ziehl-Neelsen staining, culture and histology (caseating granulomas).
MANAGEMENT
Treatment is directed at the cause: antibiotics for bacterial lymphadenitis, a full course of anti-tuberculous chemotherapy for TB, treatment of the primary plus neck dissection for metastatic carcinoma, and chemotherapy/radiotherapy for lymphoma.
💡CLINICAL PEARL: Two node-reading rules earn marks. A hard, fixed cervical node in an adult is metastatic squamous carcinoma until proven otherwise — find the primary by panendoscopy. And for a suspected lymphoma, do an excision biopsy, not just an FNAC, because subtyping needs the intact nodal architecture. TB nodes are matted and may form a cold, 'collar-stud' abscess.TUBERCULOUS LYMPHADENITIS IN DETAIL
TB cervical nodes (scrofula) deserve emphasis in this setting. They typically present as a chronic, painless, matted mass of nodes in a young adult, which may progress through stages: firm discrete nodes → matting → caseation forming a fluctuant 'cold' abscess (cold because it lacks the heat of acute inflammation) → the pus tracking through the deep fascia to form a 'collar-stud' abscess → discharge as a chronic non-healing sinus. Diagnosis is by FNAC/biopsy (caseating granulomas, acid-fast bacilli) and treatment is a full course of anti-tuberculous chemotherapy, not primarily surgery.
LYMPHOMA — WHY EXCISION BIOPSY
The reason lymphoma demands an excision (or generous core) biopsy rather than FNAC is fundamental: classifying a lymphoma — and therefore choosing treatment — depends on the nodal architecture and immunohistochemistry, which need an intact node. A cytology smear showing lymphocytes cannot distinguish reactive change from lymphoma or subtype it, so a suspicious rubbery node with systemic symptoms goes to excision biopsy.
THE METASTATIC NECK NODE — A STRUCTURED SEARCH
When a node is judged metastatic, the search for the primary is systematic: a thorough examination of the scalp, skin, oral cavity, oropharynx, nasopharynx, larynx and hypopharynx, followed by examination under anaesthesia with panendoscopy and biopsy of any suspicious mucosa, and cross-sectional imaging (CT/MRI) and increasingly PET-CT to find an occult primary. Only when a primary is truly not found (a genuine 'occult primary') is the neck itself treated. This disciplined hunt reflects the principle that treating a metastatic node without addressing its source is futile.
VIRCHOW'S NODE & DISTANT PRIMARIES
Not every metastatic cervical node comes from a head-and-neck primary. The classic exception is Virchow's node — an enlarged left supraclavicular node (Troisier's sign) — which receives thoracic-duct drainage and characteristically signals an abdominal or thoracic primary, most famously gastric carcinoma (also pancreatic, oesophageal, testicular, or lymphoma). Finding such a node therefore redirects the search to the abdomen and chest rather than the upper aerodigestive tract, a distinction that examiners like to test and that changes the entire investigative pathway.
A SUMMARY OF THE APPROACH
The safe endpoint is a firm rule set: read the nodes by consistency and matting; investigate with FNAC and ultrasound; excision-biopsy only for suspected lymphoma; panendoscopy to find the primary of a metastatic squamous node; and never blindly excise an undiagnosed node. Treatment then follows the cause. This discipline reliably distinguishes the benign reactive node from the tuberculous mass and the sinister metastasis.
🔑KEY POINTS TO REMEMBER- Three groups: reactive/inflammatory, specific infection (TB), neoplastic (metastatic carcinoma, lymphoma).
- Consistency reads the cause: soft/tender = reactive, rubbery/multiple = lymphoma, stony-hard/fixed = metastatic; matted ± cold abscess = TB.
- FNAC + ultrasound first-line; panendoscopy to find the primary of a metastatic squamous node.
- Suspected lymphoma → EXCISION biopsy (architecture needed), not FNAC; TB → ZN stain, culture, caseating granulomas.
- Treat the cause: antibiotics / anti-TB therapy / treat primary + neck dissection / chemo-radiotherapy for lymphoma.
📚SOURCES: Bailey & Love's Short Practice of Surgery; SRB's Manual of Surgery.THE CONCEPT — WHY THE SUBMANDIBULAR GLAND?
Salivary calculi (sialolithiasis) form overwhelmingly in the submandibular gland (about 80%), and understanding why explains the whole condition. The submandibular gland produces thicker, more mucinous, more alkaline saliva rich in calcium, and its duct (Wharton's duct) is long and runs uphill against gravity to open in the floor of the mouth — a perfect recipe for stasis and stone formation. A stone then obstructs salivary flow, causing swelling and predisposing to infection.
SALIVARY CALCULI — CLINICAL FEATURES
The hallmark is painful swelling of the gland at mealtimes: eating (or even the sight of food) stimulates salivation, but the obstructing stone prevents outflow, so the gland swells and aches, then gradually settles between meals. A stone may be palpable in the floor of the mouth along the duct. Recurrent obstruction predisposes to recurrent sialadenitis.
SALIVARY CALCULI — DIAGNOSIS & TREATMENT
Diagnosis is by bimanual palpation of the floor of the mouth, a plain X-ray (most submandibular stones are radio-opaque), and ultrasound, sialography or CT. Treatment depends on the site: a stone near the duct orifice can be removed intra-orally (by incising the duct), whereas a stone within the gland or a gland damaged by recurrent infection is treated by excision of the submandibular gland. Sialendoscopy is a modern minimally-invasive option.
SIALADENITIS
Sialadenitis (inflammation of a salivary gland) has several forms:
- Acute bacterial (suppurative) parotitis — classically in a dehydrated, elderly or post-operative patient with poor oral hygiene, where reduced salivary flow allows Staphylococcus aureus to ascend the duct. There is a painful, hot, swollen, tender parotid, and pus may be expressed from the duct.
- Viral — mumps, typically causing bilateral parotid swelling.
- Chronic / recurrent — from obstruction, or autoimmune disease (Sjögren's syndrome).
Acute bacterial parotitis is treated with rehydration, antibiotics, oral hygiene and salivary stimulation, with drainage if an abscess forms — and, importantly, it is largely preventable by keeping post-operative patients well hydrated with good mouth care.
💡CLINICAL PEARL: The classic story of mealtime pain and swelling of the submandibular gland is a salivary calculus until proven otherwise. And acute bacterial parotitis is a disease of the dehydrated post-operative patient — which is why hydration and oral hygiene are emphasised on surgical wards to prevent it.COMPLICATIONS OF OBSTRUCTION
Persistent salivary obstruction has consequences beyond the mealtime pain: recurrent acute sialadenitis, formation of an abscess, and eventually chronic sialadenitis with irreversible fibrosis and atrophy of the gland (which is then best excised). Understanding this progression explains why a symptomatic stone within the gland, or a gland damaged by repeated infection, is treated by gland excision rather than repeated conservative measures.
SUBMANDIBULAR GLAND EXCISION
When excision is needed, the surgeon must be aware of three nearby nerves at risk: the marginal mandibular branch of the facial nerve (injury droops the corner of the mouth), the lingual nerve (tongue sensation and taste), and the hypoglossal nerve (tongue movement). Careful technique to preserve these is central to the operation.
VIRAL & AUTOIMMUNE SIALADENITIS
Two non-bacterial forms round out the topic. Mumps, a paramyxovirus, causes painful bilateral parotid swelling in children, and is important for its complications (orchitis, meningitis, pancreatitis). Sjögren's syndrome is an autoimmune destruction of salivary and lacrimal glands causing dry mouth and dry eyes (sicca syndrome), often with bilateral gland enlargement and a raised risk of salivary lymphoma in the long term. Recognising these prevents mislabelling every swollen gland as a stone or bacterial infection.
The practical upshot across sialadenitis is that the history usually reveals the type — mealtime pain suggests obstruction, an acutely hot tender gland in a dehydrated patient suggests bacterial infection, bilateral childhood swelling suggests mumps, and chronic dryness suggests Sjögren's — which then directs the appropriate investigation and treatment.
PRINCIPLES OF MANAGEMENT SUMMARISED
Pulling the salivary infections and stones together, management follows three principles. First, relieve obstruction — remove a stone or dilate a stricture so saliva can flow. Second, treat infection — antibiotics, hydration and oral hygiene for acute bacterial sialadenitis, with drainage of any abscess. Third, remove the diseased gland when it is irreversibly damaged by recurrent infection or harbours a proximal stone. Underlying all of these is the recognition that salivary stasis is the common enemy, so measures that keep saliva flowing (hydration, sialogogues, good oral care) both treat and prevent these conditions.
A SUMMARY OF PRINCIPLES
Across salivary obstruction and infection the theme is that salivary stasis is the common enemy: relieve obstruction, treat infection, and excise an irreversibly damaged gland — while keeping saliva flowing (hydration, sialogogues, oral hygiene) to both treat and prevent disease. Mealtime submandibular swelling means a stone; a hot tender parotid in a dehydrated post-operative patient means bacterial parotitis.
🔑KEY POINTS TO REMEMBER- Salivary stones form mostly in the submandibular gland (~80%) — thick mucinous alkaline saliva + long uphill duct (Wharton's).
- Classic feature: painful gland swelling at mealtimes, settling between meals; stone often palpable in the floor of the mouth.
- Diagnose by palpation, plain X-ray (radio-opaque), ultrasound/sialography; treat by intra-oral removal (distal stone) or gland excision (proximal/recurrent).
- Acute bacterial (Staph) parotitis: dehydrated/elderly/post-op patient, hot tender parotid, pus from duct → hydration, antibiotics, oral hygiene, drainage.
- Also viral (mumps, bilateral) and autoimmune (Sjögren's); prevent bacterial parotitis with hydration and mouth care.
📚SOURCES: Bailey & Love's Short Practice of Surgery.THE CONCEPT — A DEVELOPMENTAL REMNANT
A branchial cyst is a developmental swelling arising from remnants of the branchial (pharyngeal) apparatus — the embryonic structures that form the head and neck. Most arise from incomplete obliteration of the second branchial cleft. Understanding this embryological origin explains its characteristic location and its occurrence in young people, and distinguishes it from acquired neck lumps.
BRANCHIAL CYST — CLINICAL FEATURES
It typically presents in a young adult (20–30 years) as a smooth, soft, fluctuant swelling at the junction of the upper third and lower two-thirds of the sternocleidomastoid muscle, deep to its anterior border. It is often noticed when it enlarges or becomes infected (painful and inflamed). Aspiration classically yields fluid containing cholesterol crystals. The diagnosis is supported by ultrasound and FNAC.
BRANCHIAL FISTULA & SINUS
A branchial fistula results when both ends of the branchial cleft persist, leaving a track between the skin and the pharynx; a sinus opens at one end only. The external opening is characteristically at the lower third of the neck, at the anterior border of sternocleidomastoid, and may discharge mucus or become recurrently infected. A complete fistula runs upward to open internally near the tonsillar fossa.
MANAGEMENT
The treatment of both cyst and fistula is complete surgical excision of the lesion and any tract; incomplete removal leads to recurrence, and excision is best done when the lesion is not acutely inflamed. Care is taken because the tract of a fistula runs close to important structures (the carotid vessels and cranial nerves).
THE IMPORTANT CAVEAT IN OLDER PATIENTS
A crucial teaching point: while a branchial cyst is a genuine diagnosis in the young, a cystic lateral neck swelling appearing for the first time in a patient over 40 must not be assumed to be a branchial cyst — it may be a cystic metastasis from a head-and-neck squamous carcinoma (often from an HPV-related oropharyngeal primary, e.g. the tonsil), which can present as a cystic node. Such patients need full investigation (FNAC, imaging, panendoscopy) rather than simple excision.
💡CLINICAL PEARL: Anchor the diagnosis on age and site: a fluctuant swelling at the upper-third anterior border of sternocleidomastoid in a young adult is a branchial cyst. But the same-looking cystic swelling in an older adult may be a cystic nodal metastasis from an occult head-and-neck cancer — so investigate before excising in the older patient.OTHER BRANCHIAL ANOMALIES & THE DIFFERENTIAL
The second cleft is much the commonest, but anomalies of the first, third and fourth branchial arches also occur and present at characteristic sites (a first-cleft anomaly near the ear/angle of jaw; third/fourth-arch sinuses low in the neck, sometimes causing recurrent thyroiditis). The differential for the classic branchial cyst includes a cold abscess, lymph node, or cystic metastasis, which is why FNAC and imaging are used before excision.
PRINCIPLES OF EXCISION
Complete excision requires removing the entire lining and tract; a fistula tract is best defined (sometimes with a probe or dye) and excised in continuity, occasionally needing a second, higher 'step-ladder' incision to follow it up towards the pharynx. Because the second-arch tract passes between the internal and external carotid arteries and near cranial nerves, meticulous dissection is essential.
EMBRYOLOGY MADE SIMPLE
A brief grasp of the embryology makes the anomalies memorable. The branchial (pharyngeal) apparatus consists of a series of arches separated externally by clefts and internally by pouches; each arch forms particular structures (muscles, cartilages, nerves) of the head and neck. Normally the clefts are obliterated; when a remnant of the second cleft persists it forms the classic branchial cyst, sinus or fistula in the upper lateral neck. This is why these lesions lie along a predictable line and in young people, before acquired pathology becomes common.
TIMING & OUTCOME OF SURGERY
The timing of excision matters: an acutely infected branchial cyst is treated first with antibiotics (and drainage if it abscesses), with definitive excision deferred until the inflammation settles, because operating in an inflamed field risks incomplete removal and injury to adjacent structures. With complete excision the outcome is excellent and recurrence uncommon; incomplete removal of a tract is the usual reason for recurrence. In every case in an older patient, the histology of the excised 'cyst' is reviewed to ensure a cystic metastasis has not been missed — closing the loop on the key safety caveat.
A SUMMARY FOR THE VIVA
The examinable essence is: a fluctuant swelling at the upper-third anterior border of sternocleidomastoid in a young adult is a branchial cyst (cholesterol crystals on aspiration), treated by complete excision; a fistula opens at the lower-third anterior border and runs up towards the tonsillar fossa; and — the safety caveat — a new cystic lateral neck swelling after 40 may be a cystic squamous metastasis, so investigate before excising.
🔑KEY POINTS TO REMEMBER- Branchial cyst = developmental remnant, usually of the 2nd branchial cleft; young adults (20–30).
- Smooth, fluctuant swelling at the junction of upper 1/3 and lower 2/3 of sternocleidomastoid, deep to its anterior border; aspirate shows cholesterol crystals; may get infected.
- Branchial fistula/sinus: external opening at the lower-third anterior border of SCM; complete fistula runs up to the tonsillar fossa.
- Treat both by complete surgical excision of the lesion/tract.
- Caveat: a new cystic lateral neck swelling in a patient >40 may be a cystic squamous metastasis — investigate (panendoscopy), don't just excise.
📚SOURCES: Bailey & Love's Short Practice of Surgery.THE CONCEPT
The pleomorphic adenoma is the commonest salivary gland tumour, most often arising in the parotid. It is a benign tumour also called a 'mixed' tumour because it contains a mixture of epithelial cells and a myxoid/chondroid ('cartilage-like') stroma — the 'pleomorphic' (many-formed) appearance from which it takes its name. This mixed histology and its capsule are the keys to its behaviour and treatment.
CLINICAL FEATURES
It presents as a slow-growing, painless, smooth, firm, mobile lump, classically over the angle of the jaw or in the parotid tail. Because it is benign, it does not cause a facial nerve palsy — the appearance of nerve weakness in a parotid lump should immediately raise suspicion of malignancy instead.
WHY IT MUST NOT BE ENUCLEATED
The defining surgical point is that although the tumour appears encapsulated, it has an incomplete capsule with microscopic finger-like ('pseudopod') extensions that project into the surrounding gland. If it is simply enucleated (shelled out), these extensions are left behind and the tumour recurs, often multifocally and harder to treat. Therefore it is removed by superficial parotidectomy (excising the tumour with a cuff of surrounding gland) while carefully preserving the facial nerve.
MALIGNANT TRANSFORMATION
A long-standing pleomorphic adenoma carries a small but real risk of malignant change to carcinoma ex-pleomorphic adenoma, suggested by a sudden increase in size, pain, fixation or facial nerve involvement in a previously stable lump — another reason these tumours are excised rather than watched indefinitely.
MALIGNANT TRANSFORMATION & FOLLOW-UP
The safest summary for the viva is: a benign but troublesome tumour that must be excised by superficial parotidectomy, never enucleated, with lifelong awareness that a stable lump which suddenly grows, becomes painful, fixes or causes facial weakness has probably undergone malignant transformation and needs urgent reassessment.
MICROSCOPIC & SURGICAL CORRELATION
On histology the pleomorphic adenoma shows a characteristic mix of epithelial and myoepithelial cells within a myxoid, chondroid or mucoid stroma, with the tumour bulging into its surrounding pseudo-capsule as microscopic pseudopods. This directly explains the surgical rule: because tumour extends beyond the apparent capsule, an adequate cuff of normal gland must be taken (superficial parotidectomy), and spillage during surgery must be avoided as it seeds recurrence. The clinician therefore treats even this benign tumour with an oncological respect for margins.
MANAGEMENT DECISIONS & RECURRENCE
If a pleomorphic adenoma does recur after inadequate surgery, it is characteristically multifocal and adherent, making re-operation difficult and increasing the risk to the facial nerve — which is exactly why the first operation must be done correctly. In the submandibular gland the equivalent treatment is excision of the whole gland. Longstanding or recurrent tumours are excised rather than observed because of the cumulative risk of malignant transformation, and any suspicious change prompts urgent imaging and biopsy.
THE BOTTOM LINE
Ultimately the pleomorphic adenoma is the archetypal 'benign tumour treated with oncological respect': confirmed by FNAC, removed by superficial parotidectomy with a cuff of normal gland, never enucleated or spilled, and watched for the rare late malignant transformation — principles that recur throughout salivary surgery.
🔑KEY POINTS TO REMEMBER- Commonest salivary tumour; benign 'mixed' tumour (epithelial + myxochondroid stroma); usually parotid.
- Slow-growing, painless, smooth, mobile lump at the angle of the jaw/parotid tail; no facial nerve palsy (that suggests malignancy).
- Has an incomplete capsule with pseudopod extensions → recurs if enucleated.
- Treat by superficial parotidectomy preserving the facial nerve (NOT enucleation).
- Small risk of malignant change (carcinoma ex-pleomorphic adenoma) if long-standing.
📚SOURCES: Bailey & Love's Short Practice of Surgery.THE CONCEPT
Warthin's tumour (adenolymphoma, or papillary cystadenoma lymphomatosum) is the second commonest benign salivary tumour, occurring almost exclusively in the parotid. Its distinctive histology — epithelial (glandular) tissue set in a prominent lymphoid stroma, with cystic spaces — gives it its old name 'adeno-lymphoma', though it is entirely benign and not a lymphoma. This lymphoid content also explains its behaviour on imaging.
CLINICAL FEATURES
It has a striking demographic that makes it a favourite in vivas: it occurs typically in older men and is strongly associated with smoking. It presents as a soft, cystic, slow-growing swelling in the tail of the parotid, and is notable for being the salivary tumour most likely to be bilateral or multifocal. Because it contains functioning tissue that takes up technetium, it appears as a 'hot' spot on a pertechnetate scan — a characteristic (if now rarely used) feature.
MANAGEMENT
Diagnosis is by FNAC and imaging. It is benign with negligible malignant potential, so treatment is surgical excision (superficial parotidectomy or a more limited excision), which is curative; in an elderly, frail patient a confidently diagnosed asymptomatic Warthin's tumour may even be observed.
A NOTE ON DIAGNOSIS
Diagnosis is by FNAC and imaging (ultrasound/MRI); the combination of an older male smoker with a soft cystic parotid-tail swelling, possibly bilateral, is highly suggestive. Because it is benign, the main purpose of investigation is to confidently distinguish it from a malignant tumour so that appropriate (often conservative) management can be chosen.
PATHOGENESIS & SIGNIFICANCE
Warthin's tumour is thought to arise from salivary duct epithelium entrapped within intra-parotid lymph nodes during development, which explains its unique lymphoid stroma and its confinement to the parotid (the only salivary gland with lymph nodes inside it). Its strong link with smoking is a consistent epidemiological finding. Clinically its importance is largely in being recognised as benign — so that an older male smoker with a soft, sometimes bilateral parotid-tail swelling is not over-treated as if it were a cancer.
MANAGEMENT & THE FRAIL PATIENT
Because Warthin's tumour is entirely benign and slow-growing, management is individualised: a fit patient is offered excision (superficial parotidectomy or extracapsular dissection) which is curative, whereas a confidently diagnosed, asymptomatic tumour in a frail elderly patient may be safely observed. Bilateral or multifocal disease is recognised so that both sides are assessed. The key clinical service the diagnosis provides is sparing such patients the anxiety and over-treatment appropriate only to malignant tumours.
THE BOTTOM LINE
The clinical service the Warthin's diagnosis provides is confident recognition of benignity in the older male smoker, sparing over-treatment; excision is curative when needed, and bilateral or multifocal disease is simply looked for and dealt with on its merits.
🔑KEY POINTS TO REMEMBER- Warthin's tumour (adenolymphoma) = second commonest benign salivary tumour; almost always parotid.
- Histology: epithelial tissue in a lymphoid stroma with cystic spaces (benign, not a true lymphoma).
- Classic: older men, smokers; soft cystic swelling in the parotid tail; often bilateral/multifocal; 'hot' on pertechnetate scan.
- Benign — treat by excision (curative); observation is reasonable in the frail elderly.
📚SOURCES: Bailey & Love's Short Practice of Surgery.THE CONCEPT
Adenoid cystic carcinoma is an important malignant salivary gland tumour, relatively more common in the minor salivary glands and the submandibular gland (in keeping with the rule that smaller glands harbour more malignancy). It is defined by two behaviours that shape its whole clinical course: a strong tendency to perineural invasion and a pattern of late, relentless recurrence and haematogenous spread.
CLINICAL FEATURES — THE PERINEURAL HABIT
Its hallmark is perineural (along-the-nerve) invasion, which explains why it characteristically causes pain and, in the parotid, facial nerve palsy — features that flag its malignant, infiltrative nature. It tends to spread widely along nerves well beyond the visible tumour, which is why complete surgical clearance is difficult and local recurrence is common.
SPREAD, TREATMENT & PROGNOSIS
Unlike squamous cancers, it spreads relatively little to lymph nodes but has a marked tendency to late blood-borne metastasis, especially to the lungs, which may appear many years after apparently successful treatment. Management is wide surgical excision (aiming for clear margins despite the perineural spread) with post-operative radiotherapy. The prognosis is deceptive: reasonable at 5 years but poor in the long term because of relentless late recurrence and lung metastases.
CLINICAL BEHAVIOUR
Its indolent-yet-relentless behaviour is the take-home message: it may recur or metastasise to the lungs 10–20 years after treatment, so 'cure' is judged only over very long follow-up. This late-relapsing pattern, driven by perineural and haematogenous spread, distinguishes it from the more predictable squamous cancers of the head and neck.
HISTOLOGY & MARGINS
Histologically it shows a characteristic cribriform ('Swiss-cheese') pattern of cells around cystic spaces. The relentless perineural spread means tumour cells travel far along nerve sheaths beyond the palpable mass, so margins are frequently positive despite apparently adequate excision — the rationale for routine post-operative radiotherapy. This biology is why the surgeon and oncologist plan for long-term surveillance rather than declaring cure early.
MANAGEMENT & FOLLOW-UP
Management is wide local excision to obtain the clearest possible margins, combined with post-operative radiotherapy to address the microscopic perineural spread; nodal dissection is reserved for clinically involved nodes since lymphatic spread is uncommon. Because relapse and lung metastasis appear late, patients need prolonged, often lifelong follow-up with periodic chest imaging. Even with metastatic lung disease patients may survive for years, so a considered, long-horizon approach to surveillance and treatment is appropriate.
THE BOTTOM LINE
The enduring message of adenoid cystic carcinoma is its perineural, late-relapsing behaviour: wide excision plus radiotherapy, prolonged follow-up with chest surveillance, and a prognosis judged over decades rather than years — a pattern quite distinct from the squamous cancers of the region.
🔑KEY POINTS TO REMEMBER- Adenoid cystic carcinoma = malignant salivary tumour, commoner in minor/submandibular glands.
- Hallmark perineural invasion → pain and facial nerve palsy; spreads widely along nerves.
- Little nodal spread but late haematogenous metastasis to the LUNG (years later).
- Treat by wide excision + post-operative radiotherapy.
- Prognosis reasonable short-term but poor long-term (relentless late recurrence).
📚SOURCES: Bailey & Love's Short Practice of Surgery.THE CONCEPT — ABERRANT NERVE REGENERATION
Frey's syndrome (gustatory sweating) is a well-known complication of parotid surgery (or injury), and its mechanism is an elegant piece of neurophysiology. Parotid secretion is controlled by parasympathetic secretomotor fibres; when these are cut during surgery, they can regenerate aberrantly and re-innervate the sweat glands and blood vessels of the overlying facial skin (which are normally supplied by sympathetic fibres). Because both use acetylcholine as their transmitter, the misdirected fibres now make the skin respond to the stimulus for salivation.
CLINICAL FEATURES
The result is that eating (or the anticipation of food), which should trigger salivation, instead triggers sweating, flushing and warmth over the skin of the cheek in the distribution of the operated parotid. It typically develops months after the surgery, once regeneration has occurred, and can be socially distressing. It is confirmed by the starch-iodine (Minor's) test, in which the affected skin turns blue-black on sweating after eating.
MANAGEMENT
Many mild cases need only reassurance. Troublesome symptoms are treated with topical antiperspirants (aluminium chloride) or anticholinergics, and, most effectively, botulinum toxin injections into the affected skin, which block the aberrant cholinergic transmission. It can be reduced surgically by interposing a tissue barrier at the time of parotidectomy.
PREVENTION
Because the mechanism is aberrant reinnervation after nerve division, some prevention is possible at the time of parotidectomy by interposing a barrier (such as a fascial or muscle flap, or acellular dermis) between the raw gland bed and the skin, reducing the chance that regenerating fibres reach the sweat glands.
SEVERITY & COUNSELLING
Frey's syndrome is common after parotidectomy if actively sought (many patients have a positive starch-iodine test even without complaint), but only a minority are troubled enough to want treatment. Because it appears months after an otherwise successful operation, patients should be counselled about it beforehand so that, if it develops, it is understood rather than alarming. Reassurance suffices for most; antiperspirants and, for troublesome cases, botulinum toxin manage the rest effectively.
MECHANISM RECAP & PREVENTION
The elegance of Frey's syndrome is that it is a natural experiment in nerve mis-wiring: cholinergic parasympathetic fibres meant for the parotid reconnect to cholinergic sweat glands, so a salivary stimulus produces sweating. Preventive strategies at operation (interposing fascia, muscle or acellular dermal matrix between gland bed and skin) reduce its incidence, and where it does occur, botulinum toxin gives reliable, if temporary, relief by blocking the aberrant cholinergic junctions. This clear mechanism makes it a popular short-note topic.
THE BOTTOM LINE
For the viva, Frey's syndrome is best delivered as a clean mechanism story — misdirected cholinergic reinnervation of skin sweat glands after parotidectomy — confirmed by the starch-iodine test and treated, when troublesome, with botulinum toxin, with prevention by interposing a barrier at surgery.
🔑KEY POINTS TO REMEMBER- Frey's syndrome (gustatory sweating) = complication of parotid surgery/injury.
- Cut parasympathetic secretomotor fibres regenerate onto the skin's sweat glands (both cholinergic).
- Eating triggers sweating, flushing and warmth over the cheek (instead of salivation); develops months later.
- Confirmed by the starch-iodine (Minor's) test.
- Treat with antiperspirants/anticholinergics or, best, botulinum toxin.
📚SOURCES: Bailey & Love's Short Practice of Surgery.THE CONCEPT
A ranula is a mucous (retention/extravasation) cyst arising in the floor of the mouth from the sublingual salivary gland (or occasionally the submandibular duct). The name comes from the Latin for 'little frog' (rana), because the translucent swelling under the tongue resembles a frog's belly. It forms when a sublingual duct is obstructed or damaged and mucus collects or leaks into the surrounding tissue.
CLINICAL FEATURES
The typical ranula is a soft, cystic, bluish, translucent swelling in the floor of the mouth to one side of the midline, lifting the tongue. It is usually painless but can interfere with speech and eating as it enlarges. An important variant is the 'plunging ranula', which extends downwards through (or around) the mylohyoid muscle to present as a swelling in the neck — so a neck swelling with an intra-oral component may be a plunging ranula.
MANAGEMENT
Treatment options are marsupialisation (deroofing the cyst and suturing its edges open) for simple lesions, or, because of a tendency to recur, excision of the ranula together with the sublingual gland for definitive cure, especially for recurrent or plunging ranulas.
DIFFERENTIAL
The differential of a swelling in the floor of the mouth includes a sublingual dermoid, a submandibular duct stone with obstruction, and a plunging ranula presenting in the neck; the bluish translucent appearance and relation to the sublingual gland point to a ranula, confirmed at surgery.
PATHOGENESIS
The common (simple) ranula is a mucous extravasation cyst — saliva leaks from a damaged sublingual duct and pools, walled off by granulation tissue rather than a true epithelial lining. The plunging variety occurs when this collection herniates through or around the mylohyoid muscle into the neck. Understanding that the sublingual gland is the source explains why definitive treatment often involves removing that gland, not just the cyst, to prevent recurrence.
MANAGEMENT DECISIONS
Treatment is tailored to the type: a small simple ranula may be watched or marsupialised, but because marsupialisation has a high recurrence rate, definitive management of recurrent or plunging ranulas is excision of the ranula together with the sublingual gland. A plunging ranula presenting as a neck lump is confirmed on imaging (MRI) showing its connection through mylohyoid to the sublingual space, so that the neck swelling is correctly attributed and treated at its oral source.
THE BOTTOM LINE
In summary, the ranula is a sublingual mucous cyst — bluish and translucent in the floor of the mouth, or 'plunging' through mylohyoid into the neck — cured most reliably by excision together with the sublingual gland, marsupialisation being simpler but more prone to recurrence.
🔑KEY POINTS TO REMEMBER- Ranula = mucous extravasation/retention cyst of the floor of the mouth from the sublingual gland.
- Soft, cystic, bluish, translucent swelling under the tongue ('little frog belly'); may impair speech/eating.
- 'Plunging ranula' extends through mylohyoid to present as a neck swelling.
- Treat by marsupialisation, or excision with the sublingual gland (definitive; for recurrent/plunging types).
📚SOURCES: Bailey & Love's Short Practice of Surgery.THE CONCEPT
A cystic hygroma is a congenital malformation of the lymphatic system (a lymphangioma) — a collection of dilated lymphatic channels and cysts that failed to connect normally to the venous system during development. It is essentially a benign, fluid-filled lymphatic swelling, and because it is filled with clear lymph, it has one of the most characteristic physical signs in surgery.
CLINICAL FEATURES
It usually presents at birth or in early infancy as a soft, fluctuant, painless swelling, classically in the posterior triangle of the neck. The defining sign is that it is brilliantly transilluminable — a torch held against it lights it up dramatically because it is full of clear lymph, distinguishing it from solid or blood-filled swellings. It is soft and compressible, and may increase in size with upper respiratory infections or if it bleeds internally. A large cystic hygroma can compress the airway or interfere with feeding, and rarely presents antenatally.
MANAGEMENT
Diagnosis is confirmed by ultrasound (and MRI to define extent). Treatment is by surgical excision — which can be difficult because the lesion infiltrates around vital structures — or by injection sclerotherapy (e.g. with OK-432/picibanil), which is increasingly used, particularly for macrocystic lesions. Airway compromise takes priority and may require urgent intervention.
💡CLINICAL PEARL: The exam sign to state is brilliant transillumination: a soft, fluctuant swelling in the posterior triangle of an infant that lights up brightly on transillumination is a cystic hygroma. This single sign, plus the age and site, essentially makes the clinical diagnosis.COMPLICATIONS
A large or rapidly enlarging cystic hygroma can cause airway obstruction, feeding difficulty, or sudden painful enlargement from infection or intracystic haemorrhage — so airway assessment takes priority, and antenatally diagnosed large lesions may need planned delivery/airway management.
PATHOGENESIS & VARIANTS
Cystic hygroma results from a failure of the developing lymphatic sacs to establish normal drainage into the venous system, so lymph accumulates in dilated channels. Lymphatic malformations are classified as macrocystic, microcystic or mixed, which influences treatment — macrocystic lesions respond well to sclerotherapy, while infiltrative microcystic lesions are harder to eradicate. Association with chromosomal abnormalities (e.g. Turner's syndrome) when detected antenatally is an additional point of significance.
MANAGEMENT & AIRWAY PRIORITY
Because a large cervical cystic hygroma can threaten the airway, airway assessment and protection take precedence, and antenatally diagnosed lesions may require a planned delivery with airway expertise available. Definitive treatment is by surgical excision or sclerotherapy (e.g. OK-432, bleomycin); surgery can be difficult because the malformation infiltrates around nerves and vessels, so complete excision is not always possible and recurrence can occur, making sclerotherapy an attractive option for many macrocystic lesions.
THE BOTTOM LINE
The examinable essence is a soft, brilliantly transilluminable posterior-triangle swelling in an infant, treated by excision or sclerotherapy, with airway assessment taking priority in large lesions — a lymphatic malformation whose single best sign is transillumination.
🔑KEY POINTS TO REMEMBER- Cystic hygroma = congenital lymphatic malformation (lymphangioma) — dilated lymph-filled cysts.
- Presents at birth/infancy; soft, fluctuant, painless swelling, classically in the posterior triangle.
- Brilliantly transilluminable (full of clear lymph) — the key diagnostic sign; may compress the airway/feeding.
- Confirm with ultrasound/MRI; treat by surgical excision or sclerotherapy (e.g. OK-432).
📚SOURCES: Bailey & Love's Short Practice of Surgery.THE CONCEPT
A carotid body tumour (chemodectoma, or carotid paraganglioma) is a rare tumour arising from the chemoreceptor cells of the carotid body, which sit at the bifurcation of the common carotid artery and normally sense blood oxygen, carbon dioxide and pH. It is usually benign and very slow-growing, but its intimate relationship with the carotid vessels makes it surgically important and hazardous. It can be sporadic or familial, and is commoner in people living at high altitude (chronic hypoxia stimulates the carotid body).
CLINICAL FEATURES — THE DIAGNOSTIC SIGNS
It presents as a slowly enlarging, painless, pulsatile lump at the angle of the jaw / upper anterior triangle. Two classic signs reflect its origin at the fixed carotid bifurcation: it is mobile from side to side but not up and down (Fontaine's sign), being tethered to the artery; and it may be pulsatile with a bruit. On angiography or CT it characteristically splays the carotid bifurcation, producing the 'lyre sign'.
MANAGEMENT
Diagnosis is made on imaging — duplex ultrasound, CT/MR angiography — which shows the splayed bifurcation. Biopsy is contraindicated because the tumour is highly vascular. Treatment is careful surgical excision by a vascular surgeon (with the potential need for vascular reconstruction), ideally while the tumour is small, as larger tumours encase the vessels and cranial nerves and are far more dangerous to remove.
A NOTE ON FUNCTION
Although derived from chemoreceptor tissue, most carotid body tumours are non-functioning (do not secrete catecholamines); the rare secretory paraganglioma can cause phaeochromocytoma-like symptoms, which is worth screening for before surgery in suspicious or familial cases.
SHAMBLIN CLASSIFICATION & RISK
Carotid body tumours are graded by the Shamblin classification according to how much they encase the carotid vessels (I = localised, II = partially surrounding, III = completely encasing), which predicts the difficulty and vascular risk of excision. This is why early excision while the tumour is small is advised, and why surgery is undertaken by a vascular surgeon prepared for arterial repair. Pre-operative embolisation may be used for large, very vascular tumours to reduce bleeding.
DIAGNOSIS & THE DANGER OF BIOPSY
The diagnosis is confirmed by imaging that shows the splayed carotid bifurcation and a highly vascular mass (duplex ultrasound, CT or MR angiography), so that needle or open biopsy is avoided — it risks torrential haemorrhage and offers nothing that imaging cannot. Excision is planned according to the Shamblin grade, with vascular control and the readiness to reconstruct the carotid; familial and multiple tumours prompt genetic assessment and screening for a secretory (catecholamine-producing) paraganglioma before surgery.
THE BOTTOM LINE
The core of the carotid body tumour is a pulsatile lump that moves side-to-side but not up-down, splays the carotid bifurcation ('lyre sign'), must never be biopsied, and is excised (graded by Shamblin) by a vascular surgeon — with screening for a secretory paraganglioma in familial cases.
🔑KEY POINTS TO REMEMBER- Carotid body tumour (chemodectoma/paraganglioma) = tumour of carotid body chemoreceptors at the carotid bifurcation; usually benign, slow-growing; familial/high-altitude links.
- Painless pulsatile lump at the angle of the jaw; mobile side-to-side but not up-down (Fontaine's sign); bruit.
- Imaging shows splaying of the carotid bifurcation ('lyre sign'); diagnose with duplex/CT-MR angiography.
- Biopsy contraindicated (very vascular); treat by careful surgical excision (vascular surgeon).
📚SOURCES: Bailey & Love's Short Practice of Surgery.